col-wideJob Description:The Josep Carreras Leukaemia Research Institute (IJC) is a non-profit research institute based in Barcelona dedicated to advancing the understanding of leukemia and related disorders, in collaboration with the University of Barcelona and the Autonomous University of Barcelona. The IJC has laboratories in 5 clinical campuses: i) Hospital Clínic, ii) Hospital de Sant Pau and iii) Hospital Germans Trias Pujol iv) Hospital del Mar and v) Hospital Josep Trueta Girona. IJC serves as a collaborative center for basic researchers and physicians to work together on fundamental clinical and biological aspects of leukemia. The IJC offers an excellent work environment based on a multidisciplinary fusion of state-of-the-art ideas and facilities.We are looking for a junior postdoctoral researcher in the field of Inmuno Biology to join Dr. Esteller's Cancer Epigenetics Group.Dr. Manel Esteller is the Director of the Josep Carreras Leukaemia Research Institute and the principal investigator of the Cancer Epigenetics Group, which is involved in the analysis of the type and mechanisms of epigenetic alterations in cancer cells, including aberrant changes in DNA methylation and histone modifications in cancer, study of the epigenetics machinery and associated mutations, and finally, testing of epigenetic drugs.**What we need**- PhD in Biomedical Sciences or similar.- Experience in epigenetic research and related bioinformatics analysis is an important plus.- You have good communication skills in English and can work independently.- You are motivated to achieve a high quality in your work.**What we offer**- 3-years contract with the possibility of being extended.- The opportunity to contribute to cutting-edge research projects in Molecular Biology.- Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.- The stimulating environment of the Barcelona metropolitan area.- Full time contract.- Possible start date: June 2023- The stimulating environment of the IJC and its scientific network.**Deadline for Applications**:**Who we are?**Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukemia and other hematologic malignancies.The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukemias and other malignant hematological pathologies in order to be able to prevent them. We will work for a future in which all leukemias will be curable.The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.This EC initiative aims to promote training, professional development, and mobility for all European scientists. The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.**IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.
